REST API DAN ODOO 17 PADA APLIKASI TRACER ALUMNI UIN MAULANA MALIK IBRAHIM MALANG BERBASIS FLUTTER
DOI:
https://doi.org/10.70038/jentik.v2i3.136Keywords:
odoo-17, tracer alumni, flutter, rest-apiAbstract
Aplikasi tracer alumni berbasis Flutter dengan integrasi database Odoo 17 dikembangkan untuk mempermudah UIN Maulana Malik Ibrahim Malang dalam memantau perkembangan lulusan. Sistem ini memungkinkan pengelolaan data alumni secara real-time melalui REST API yang menghubungkan frontend Flutter dengan backend Odoo 17. Teknologi ini memberikan kemudahan bagi alumni untuk memperbarui data kapan saja dan di mana saja, serta memfasilitasi evaluasi kualitas pendidikan dan relevansi kurikulum terhadap dunia kerja. Flutter dipilih karena kemampuannya dalam pengembangan lintas platform dan antarmuka yang responsif. Integrasi dengan Odoo 17 menawarkan pengelolaan data yang efisien dan fleksibel. Implementasi ini mendukung digitalisasi layanan kampus, mempercepat proses pengumpulan data, dan memperkuat hubungan antara alumni dan institusi, sekaligus menyediakan informasi penting untuk pengambilan keputusan strategis terkait peningkatan mutu pendidikan dan jaringan profesional.
References
K. H. Kuck, “Catheter ablation or medical therapy to delay progression of atrial fibrillation: The randomized controlled atrial fibrillation progression trial (ATTEST),” Europace, vol. 23, no. 3, pp. 362–369, 2021, doi: 10.1093/europace/euaa298.
W. Li, “A novel long short-term memory neural-network-based self-excited force model of limit cycle oscillations of nonlinear flutter for various aerodynamic configurations,” Nonlinear Dyn., vol. 100, no. 3, pp. 2071–2087, 2020, doi: 10.1007/s11071-020-05631-5.
W. W. Su, “Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial,” Hear. Rhythm, vol. 17, no. 11, pp. 1841–1847, 2020, doi: 10.1016/j.hrthm.2020.06.020.
X. Ma, “A review of flow-induced vibration energy harvesters,” Energy Conversion and Management, vol. 254. 2022. doi: 10.1016/j.enconman.2022.115223.
M. J. Kovacs, “Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): Double blind randomised controlled trial,” BMJ, vol. 373, 2021, doi: 10.1136/bmj.n1205.
J. L. Chan, “Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review,” Journal of Neurology, vol. 268, no. 10. pp. 3517–3548, 2021. doi: 10.1007/s00415-021-10458-0.
H. Kim, “Flow-induced snap-through triboelectric nanogenerator,” Nano Energy, vol. 68, 2020, doi: 10.1016/j.nanoen.2019.104379.
J. Trotman, “Zanubrutinib for the treatment of patients with Waldenstrom macroglobulinemia: 3 years of follow-up,” Blood, vol. 136, no. 18, pp. 2027–2037, 2020, doi: 10.1182/BLOOD.2020006449.
S. Raghunath, “Deep Neural Networks Can Predict New-Onset Atrial Fibrillation from the 12-Lead ECG and Help Identify Those at Risk of Atrial Fibrillation-Related Stroke,” Circulation, vol. 143, no. 13, pp. 1287–1298, 2021, doi: 10.1161/CIRCULATIONAHA.120.047829.
R. J. Mentz, “Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure,” J. Am. Coll. Cardiol., vol. 82, no. 1, pp. 1–12, 2023, doi: 10.1016/j.jacc.2023.04.019.
N. F. Marrouche, “Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design,” J. Cardiovasc. Electrophysiol., vol. 32, no. 4, pp. 916–924, 2021, doi: 10.1111/jce.14957.
E. Freisinger, “Mortality after use of paclitaxel-based devices in peripheral arteries: A real-world safety analysis,” Eur. Heart J., vol. 41, no. 38, pp. 3732–3739, 2020, doi: 10.1093/eurheartj/ehz698.
A. R. Weiss, “Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial,” Lancet Oncol., vol. 21, no. 8, pp. 1110–1122, 2020, doi: 10.1016/S1470-2045(20)30325-9.
S. Jame, “Stroke and thromboembolism prevention in atrial fibrillation,” Heart, vol. 106, no. 1. pp. 10–17, 2020. doi: 10.1136/heartjnl-2019-314898.
A. K. Pandey, “Sodium-glucose co-transporter inhibitors and atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials,” J. Am. Heart Assoc., vol. 10, no. 17, 2021, doi: 10.1161/JAHA.121.022222.
M. K. Turagam, “Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry,” Circulation, vol. 148, no. 1, pp. 35–46, 2023, doi: 10.1161/CIRCULATIONAHA.123.064959.
I. Kawamura, “How does the level of pulmonary venous isolation compare between pulsed field ablation and thermal energy ablation (radiofrequency, cryo, or laser)?,” Europace, vol. 23, no. 11, pp. 1757–1766, 2021, doi: 10.1093/europace/euab150.
Y. Xie, “Long-term cardiovascular outcomes of COVID-19,” Nat. Med., vol. 28, no. 3, pp. 583–590, 2022, doi: 10.1038/s41591-022-01689-3.
M. K. Chung, “Atrial Fibrillation: JACC Council Perspectives,” Journal of the American College of Cardiology, vol. 75, no. 14. pp. 1689–1713, 2020. doi: 10.1016/j.jacc.2020.02.025.
P. Elias, “The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19,” Mayo Clin. Proc., vol. 95, no. 10, pp. 2099–2109, 2020, doi: 10.1016/j.mayocp.2020.07.028.
hafiz, muhammad ., Dahri, N., & Hadi, H. S. (2023). WEB-BASED HONEY HARVEST SCHEDULING IN THE MUARO BOTUAK JAYA (MBJ) GROUP. Jurnal Manajemen Teknologi Informatika, 1(3), 134-142. https://doi.org/10.70038/jentik.v1i3.57
I. Klem, “Relationship of LVEF and Myocardial Scar to Long-Term Mortality Risk and Mode of Death in Patients with Nonischemic Cardiomyopathy,” Circulation, vol. 143, no. 14, pp. 1343–1358, 2021, doi: 10.1161/CIRCULATIONAHA.120.048477.
B. Peltzer, “Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19,” J. Cardiovasc. Electrophysiol., vol. 31, no. 12, pp. 3077–3085, 2020, doi: 10.1111/jce.14770.
W. J. Li, “SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials,” Cardiovascular Diabetology, vol. 19, no. 1. 2020. doi: 10.1186/s12933-020-01105-5.
X. Li, “Healthy Sleep Patterns and Risk of Incident Arrhythmias,” J. Am. Coll. Cardiol., vol. 78, no. 12, pp. 1197–1207, 2021, doi: 10.1016/j.jacc.2021.07.023.
A. Velleca, “The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients,” J. Hear. Lung Transplant., vol. 42, no. 5, 2023, doi: 10.1016/j.healun.2022.10.015.
K. Zhou, “Stationary/nonstationary stochastic response analysis of composite laminated plates with aerodynamic and thermal loads,” Int. J. Mech. Sci., vol. 173, 2020, doi: 10.1016/j.ijmecsci.2020.105461.
L. Wang, “Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017,” Heart, vol. 107, no. 11, pp. 881–887, 2021, doi: 10.1136/heartjnl-2020-317656.
N. Vinter, “Trends in excess mortality associated with atrial fibrillation over 45 years (Framingham Heart Study): Community based cohort study,” BMJ, vol. 370, 2020, doi: 10.1136/bmj.m2724.
C. Dong, “Cardiovascular disease burden attributable to dietary risk factors from 1990 to 2019: A systematic analysis of the Global Burden of Disease study,” Nutr. Metab. Cardiovasc. Dis., vol. 32, no. 4, pp. 897–907, 2022, doi: 10.1016/j.numecd.2021.11.012.
A. R. Mato, “Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.,” N. Engl. J. Med., vol. 389, no. 1, pp. 33–44, 2023, doi: 10.1056/NEJMoa2300696.
T. Facon, “Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma,” Blood, vol. 137, no. 26, pp. 3616–3628, 2021, doi: 10.1182/blood.2020008787.
B. A. Teplitzky, “Deep learning for comprehensive ECG annotation,” Hear. Rhythm, vol. 17, no. 5, pp. 881–888, 2020, doi: 10.1016/j.hrthm.2020.02.015.
F. K. Wegner, “Prospective blinded Evaluation of the smartphone-based AliveCor Kardia ECG monitor for Atrial Fibrillation detection: The PEAK-AF study,” Eur. J. Intern. Med., vol. 73, pp. 72–75, 2020, doi: 10.1016/j.ejim.2019.11.018.
X. J. Dong, “Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019,” Europace, vol. 25, no. 3, pp. 793–803, 2023, doi: 10.1093/europace/euac237.
J. A. Joglar, “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,” J. Am. Coll. Cardiol., vol. 83, no. 1, pp. 109–279, 2024, doi: 10.1016/j.jacc.2023.08.017.
Y. Wang, “Electrocardiogram analysis of patients with different types of COVID-19,” Ann. Noninvasive Electrocardiol., vol. 25, no. 6, 2020, doi: 10.1111/anec.12806.
A. Huda, “A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy,” Nat. Commun., vol. 12, no. 1, 2021, doi: 10.1038/s41467-021-22876-9.
B. Wu, “Characterization of vibration amplitude of nonlinear bridge flutter from section model test to full bridge estimation,” J. Wind Eng. Ind. Aerodyn., vol. 197, 2020, doi: 10.1016/j.jweia.2019.104048.
C. Chen, “Automated arrhythmia classification based on a combination network of CNN and LSTM,” Biomed. Signal Process. Control, vol. 57, 2020, doi: 10.1016/j.bspc.2019.101819.
L. Koltowski, “Kardia mobile applicability in clinical practice: a comparison of kardia mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center,” Cardiol. J., vol. 28, no. 4, pp. 543–548, 2021, doi: 10.5603/CJ.a2019.0001.
P. Grimison, “Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial,” Ann. Oncol., vol. 31, no. 11, pp. 1553–1560, 2020, doi: 10.1016/j.annonc.2020.07.020.
M. Boudreau, “A parametric study and optimization of the fully-passive flapping-foil turbine at high Reynolds number,” Renew. Energy, vol. 146, pp. 1958–1975, 2020, doi: 10.1016/j.renene.2019.08.013.
X. Zhou, “Vibration and flutter characteristics of GPL-reinforced functionally graded porous cylindrical panels subjected to supersonic flow,” Acta Astronaut., vol. 183, pp. 89–100, 2021, doi: 10.1016/j.actaastro.2021.03.003.
A. Ullah, “Classification of arrhythmia by using deep learning with 2-D ECG spectral image representation,” Remote Sens., vol. 12, no. 10, 2020, doi: 10.3390/rs12101685.
J. Patocka, “Digoxin: Pharmacology and toxicology—A review,” Environmental Toxicology and Pharmacology, vol. 79. 2020. doi: 10.1016/j.etap.2020.103400.
G. Petmezas, “Automated Atrial Fibrillation Detection using a Hybrid CNN-LSTM Network on Imbalanced ECG Datasets,” Biomed. Signal Process. Control, vol. 63, 2021, doi: 10.1016/j.bspc.2020.102194.
M. D. Yazdi, “Long-Term Association of Air Pollution and Hospital Admissions among Medicare Participants Using a Doubly Robust Additive Model,” Circulation, vol. 143, no. 16, pp. 1584–1596, 2021, doi: 10.1161/CIRCULATIONAHA.120.050252.
M. Høybye, “In-Hospital vs. Out-of-Hospital Cardiac Arrest: Patient Characteristics and Survival,” Resuscitation, vol. 158, pp. 157–165, 2021, doi: 10.1016/j.resuscitation.2020.11.016.
T. A. Zelniker, “Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial,” Circulation, vol. 141, no. 15, pp. 1227–1234, 2020, doi: 10.1161/CIRCULATIONAHA.119.044183.
J. Aman, “Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial,” Lancet Respir. Med., vol. 9, no. 9, pp. 957–968, 2021, doi: 10.1016/S2213-2600(21)00237-X.
S. Opat, “The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma,” Clin. Cancer Res., vol. 27, no. 23, pp. 6323–6332, 2021, doi: 10.1158/1078-0432.CCR-21-1704.
K. A. Rogers, “Phase 2 study of ibrutinib in classic and variant hairy cell leukemia,” Blood, vol. 137, no. 25, pp. 3473–3483, 2021, doi: 10.1182/blood.2020009688.
D. R. Musikantow, “Atrial Fibrillation in Patients Hospitalized With COVID-19: Incidence, Predictors, Outcomes, and Comparison to Influenza,” JACC Clin. Electrophysiol., vol. 7, no. 9, pp. 1120–1130, 2021, doi: 10.1016/j.jacep.2021.02.009.
P. Shivashankar, “Review on the use of piezoelectric materials for active vibration, noise, and flow control,” Smart Materials and Structures, vol. 29, no. 5. 2020. doi: 10.1088/1361-665X/ab7541.
P. T. Pham, “Dynamic models of axially moving systems: A review,” Nonlinear Dynamics, vol. 100, no. 1. pp. 315–349, 2020. doi: 10.1007/s11071-020-05491-z.
D. Zentner, “Management of People With a Fontan Circulation: a Cardiac Society of Australia and New Zealand Position statement,” Hear. Lung Circ., vol. 29, no. 1, pp. 5–39, 2020, doi: 10.1016/j.hlc.2019.09.010.
J. S. Steinberg, “Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence among Patients with Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial,” JAMA - J. Am. Med. Assoc., vol. 323, no. 3, pp. 248–255, 2020, doi: 10.1001/jama.2019.21187.
Y. Kakihana, “Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial,” Lancet Respir. Med., vol. 8, no. 9, pp. 863–872, 2020, doi: 10.1016/S2213-2600(20)30037-0.
K. Zhou, “Static equilibrium configuration and nonlinear dynamics of slightly curved cantilevered pipe conveying fluid,” J. Sound Vib., vol. 490, 2021, doi: 10.1016/j.jsv.2020.115711.
B. H. Buck, “Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke: The per diem randomized clinical trial,” JAMA - J. Am. Med. Assoc., vol. 325, no. 21, pp. 2160–2168, 2021, doi: 10.1001/jama.2021.6128.
K. Li, “Performance enhancement for a magnetic-coupled bi-stable flutter-based energy harvester,” Smart Mater. Struct., vol. 29, no. 8, 2020, doi: 10.1088/1361-665X/ab9238.
B. J. R. Buckley, “Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke,” Stroke, vol. 53, no. 5, pp. 1759–1763, 2022, doi: 10.1161/STROKEAHA.121.037316.
H. Dai, “Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: Results from the Global Burden of Disease Study 2017,” Eur. Hear. J. - Qual. Care Clin. Outcomes, vol. 7, no. 6, pp. 574–582, 2021, doi: 10.1093/ehjqcco/qcaa061.
M. E. Bass, “Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus,” J. Thromb. Thrombolysis, vol. 52, no. 2, pp. 517–522, 2021, doi: 10.1007/s11239-020-02371-6.
Y. H. Kim, “2019 APHRS expert consensus statement on three-dimensional mapping systems for tachycardia developed in collaboration with HRS, EHRA, and LAHRS,” Journal of Arrhythmia, vol. 36, no. 2. pp. 215–270, 2020. doi: 10.1002/joa3.12308.
J. Jensen, “Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial,” Am. Heart J., vol. 228, pp. 47–56, 2020, doi: 10.1016/j.ahj.2020.07.011.
A. Shariati, “On the vibrations and stability of moving viscoelastic axially functionally graded nanobeams,” Materials (Basel)., vol. 13, no. 7, 2020, doi: 10.3390/ma13071707.
S. Kodali, “Feasibility Study of the Transcatheter Valve Repair System for Severe Tricuspid Regurgitation,” J. Am. Coll. Cardiol., vol. 77, no. 4, pp. 345–356, 2021, doi: 10.1016/j.jacc.2020.11.047.
C. C. Cheung, “Management of Atrial Fibrillation in 2021: An Updated Comparison of the Current CCS/CHRS, ESC, and AHA/ACC/HRS Guidelines,” Canadian Journal of Cardiology, vol. 37, no. 10. pp. 1607–1618, 2021. doi: 10.1016/j.cjca.2021.06.011.
H. Guo, “On the flutter of matrix cracked laminated composite plates reinforced with graphene nanoplatelets,” Thin-Walled Struct., vol. 158, 2021, doi: 10.1016/j.tws.2020.107161.
J. G. Andrade, “Progression of Atrial Fibrillation after Cryoablation or Drug Therapy,” N. Engl. J. Med., vol. 388, no. 2, pp. 105–116, 2023, doi: 10.1056/NEJMoa2212540.
F. Bandera, “Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis,” JACC Cardiovasc. Imaging, vol. 15, no. 1, pp. 17–29, 2022, doi: 10.1016/j.jcmg.2021.06.022.
H. Li, “Global, regional, and national burden of disease study of atrial fibrillation/flutter, 1990–2019: results from a global burden of disease study, 2019,” BMC Public Health, vol. 22, no. 1, 2022, doi: 10.1186/s12889-022-14403-2.
T. J. Bunch, “Long-term outcomes after low power, slower movement versus high power, faster movement irrigated-tip catheter ablation for atrial fibrillation,” Hear. Rhythm, vol. 17, no. 2, pp. 184–189, 2020, doi: 10.1016/j.hrthm.2019.08.001.
T. M. Markman, “Durability of posterior wall isolation after catheter ablation among patients with recurrent atrial fibrillation,” Hear. Rhythm, vol. 17, no. 10, pp. 1740–1744, 2020, doi: 10.1016/j.hrthm.2020.05.005.
M. Takigawa, “Mechanism of recurrence of atrial tachycardia: Comparison between first versus redo procedures in a high-resolution mapping system,” Circ. Arrhythmia Electrophysiol., vol. 13, no. 1, 2020, doi: 10.1161/CIRCEP.119.007273.
K. Huang, “Flutter analysis of laminated composite quadrilateral plates reinforced with graphene nanoplatelets using the element-free IMLS-Ritz method,” Aerosp. Sci. Technol., vol. 103, 2020, doi: 10.1016/j.ast.2020.105915.
J. G. Andrade, “The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation,” Can. J. Cardiol., vol. 36, no. 12, pp. 1847–1948, 2020, doi: 10.1016/j.cjca.2020.09.001.
S. Tohoku, “Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation,” Europace, vol. 25, no. 2, pp. 433–440, 2023, doi: 10.1093/europace/euac211.
M. Kuniss, “Cryoballoon ablation vs. antiarrhythmic drugs: First-line therapy for patients with paroxysmal atrial fibrillation,” Europace, vol. 23, no. 7, pp. 1033–1041, 2021, doi: 10.1093/europace/euab029.
V. Caponnetto, “Comorbidities of primary headache disorders: a literature review with meta-analysis,” Journal of Headache and Pain, vol. 22, no. 1. 2021. doi: 10.1186/s10194-021-01281-z.
A. E. McKechnie, “Thermoregulation in desert birds: scaling and phylogenetic variation in heat tolerance and evaporative cooling,” Journal of Experimental Biology, vol. 224. 2021. doi: 10.1242/jeb.229211.
W. Sun, “Wind energy harvesting based on fluttering double-flag type triboelectric nanogenerators,” Nano Energy, vol. 70, 2020, doi: 10.1016/j.nanoen.2020.104526.
W. Tian, “Suppression of nonlinear aeroelastic responses for a cantilevered trapezoidal plate in hypersonic airflow using an energy harvester enhanced nonlinear energy sink,” Int. J. Mech. Sci., vol. 172, 2020, doi: 10.1016/j.ijmecsci.2020.105417.
“Summary of Global Burden of Disease Study Methods,” J. Am. Coll. Cardiol., vol. 80, no. 25, pp. 2372–2425, 2022, doi: 10.1016/j.jacc.2022.11.001.
S. Cassady, “Right Heart Failure in Pulmonary Hypertension,” Cardiology Clinics, vol. 38, no. 2. pp. 243–255, 2020. doi: 10.1016/j.ccl.2020.02.001.
A. Aryana, “Concomitant Pulmonary Vein and Posterior Wall Isolation Using Cryoballoon With Adjunct Radiofrequency in Persistent Atrial Fibrillation,” JACC Clin. Electrophysiol., vol. 7, no. 2, pp. 187–196, 2021, doi: 10.1016/j.jacep.2020.08.016.
Z. Li, “Recent progress on flutter-based wind energy harvesting,” International Journal of Mechanical System Dynamics, vol. 2, no. 1. pp. 82–98, 2022. doi: 10.1002/msd2.12035.
M. Kassem, “Active dynamic vibration absorber for flutter suppression,” J. Sound Vib., vol. 469, 2020, doi: 10.1016/j.jsv.2019.115110.
G. M. M. De Oliveira, “Cardiovascular statistics–brazil 2020,” Arq. Bras. Cardiol., vol. 115, no. 3, pp. 308–439, 2020, doi: 10.36660/abc.20200812.
M. Bertini, “Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement,” Europace, vol. 22, no. 12, pp. 1848–1854, 2020, doi: 10.1093/europace/euaa258.
A. Hochhaus, “Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study,” Leukemia, vol. 34, no. 8, pp. 2125–2137, 2020, doi: 10.1038/s41375-020-0915-9.
F. L. Pagan, “Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial,” JAMA Neurol., vol. 77, no. 3, pp. 309–317, 2020, doi: 10.1001/jamaneurol.2019.4200.
M. Zhang, “Tuned mass damper for self-excited vibration control: Optimization involving nonlinear aeroelastic effect,” J. Wind Eng. Ind. Aerodyn., vol. 220, 2022, doi: 10.1016/j.jweia.2021.104836.
A. Goldman, “Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy,” J. Am. Coll. Cardiol., vol. 78, no. 18, pp. 1800–1813, 2021, doi: 10.1016/j.jacc.2021.08.044.
G. Huang, “Effect of dielectric barrier discharge plasma actuator on the dynamic moment behavior of pitching airfoil at low Reynolds number,” Phys. Fluids, vol. 33, no. 4, 2021, doi: 10.1063/5.0048235.
G. Karabourniotis, “The optical properties of leaf structural elements and their contribution to photosynthetic performance and photoprotection,” Plants, vol. 10, no. 7. 2021. doi: 10.3390/plants10071455.
S. Rao, “An Explainable Transformer-Based Deep Learning Model for the Prediction of Incident Heart Failure,” IEEE J. Biomed. Heal. Informatics, vol. 26, no. 7, pp. 3362–3372, 2022, doi: 10.1109/JBHI.2022.3148820.
E. I. Pachon-M, “Relation of Fractionated Atrial Potentials With the Vagal Innervation Evaluated by Extracardiac Vagal Stimulation During Cardioneuroablation,” Circ. Arrhythmia Electrophysiol., vol. 13, no. 4, 2020, doi: 10.1161/CIRCEP.119.007900.
C. Hassager, “Duration of Device-Based Fever Prevention after Cardiac Arrest.,” N. Engl. J. Med., vol. 388, no. 10, pp. 888–897, 2023, doi: 10.1056/NEJMoa2212528.
J. Sun, “Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2019: a systematic analysis of Global Burden of Disease Study 2019,” BMC Med., vol. 21, no. 1, 2023, doi: 10.1186/s12916-023-02925-4.
P. Xue, “Bioinspired MXene-Based Soft Actuators Exhibiting Angle-Independent Structural Color,” Nano-Micro Lett., vol. 15, no. 1, 2023, doi: 10.1007/s40820-022-00977-4.
H. L. Li, “Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis,” Cardiovasc. Diabetol., vol. 20, no. 1, 2021, doi: 10.1186/s12933-021-01293-8.
C. Sun, “Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib,” Blood, vol. 136, no. 1, pp. 93–105, 2020, doi: 10.1182/blood.2019003715.
J. Wang, “An intelligent computer-aided approach for atrial fibrillation and atrial flutter signals classification using modified bidirectional LSTM network,” Inf. Sci. (Ny)., vol. 574, pp. 320–332, 2021, doi: 10.1016/j.ins.2021.06.009.
D. Chang, “Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin,” Journal of the American College of Cardiology, vol. 75, no. 23. pp. 2992–2993, 2020. doi: 10.1016/j.jacc.2020.04.032.
G. C. Fernandes, “Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials,” Hear. Rhythm, vol. 18, no. 7, pp. 1098–1105, 2021, doi: 10.1016/j.hrthm.2021.03.028.
G. Gao, “A novel two-degree-of-freedom model of nonlinear self-excited force for coupled flutter instability of bridge decks,” J. Sound Vib., vol. 480, 2020, doi: 10.1016/j.jsv.2020.115406.
A. Yafasova, “Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis,” J. Am. Coll. Cardiol., vol. 76, no. 7, pp. 767–777, 2020, doi: 10.1016/j.jacc.2020.06.038.
T. D. Shanafelt, “Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial,” Blood, vol. 140, no. 2, pp. 112–120, 2022, doi: 10.1182/blood.2021014960.
E. M. Stein, “Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial,” Lancet Haematol., vol. 7, no. 4, 2020, doi: 10.1016/S2352-3026(19)30284-4.
J. Liu, “Wind energy harvesting using piezoelectric macro fiber composites based on flutter mode,” Microelectron. Eng., vol. 231, 2020, doi: 10.1016/j.mee.2020.111333.
A. D. Desai, “Management of Arrhythmias Associated with COVID-19,” Current Cardiology Reports, vol. 23, no. 1. 2021. doi: 10.1007/s11886-020-01434-7.
T. Li, “Nonlinear unsteady bridge aerodynamics: Reduced-order modeling based on deep LSTM networks,” J. Wind Eng. Ind. Aerodyn., vol. 198, 2020, doi: 10.1016/j.jweia.2020.104116.
J. G. Andrade, “Cryoablation or drug therapy for initial treatment of atrial fibrillation,” N. Engl. J. Med., vol. 384, no. 4, pp. 305–315, 2021, doi: 10.1056/NEJMoa2029980.
A. J. Camm, “The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review,” Journal of the American College of Cardiology, vol. 79, no. 19. pp. 1932–1948, 2022. doi: 10.1016/j.jacc.2022.03.337.
A. Ioannou, “Conventional heart failure therapy in cardiac ATTR amyloidosis,” Eur. Heart J., vol. 44, no. 31, pp. 2893–2907, 2023, doi: 10.1093/eurheartj/ehad347.
Z. Zhou, “Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis,” Stroke, vol. 52, no. 5, pp. 1545–1556, 2021, doi: 10.1161/STROKEAHA.120.031623.
M. Hamadani, “Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study,” Lancet Haematol., vol. 8, no. 6, 2021, doi: 10.1016/S2352-3026(21)00103-4.
C. Shao, “Coronary Artery Disease: From Mechanism to Clinical Practice,” Advances in Experimental Medicine and Biology, vol. 1177. pp. 1–36, 2020. doi: 10.1007/978-981-15-2517-9_1.
L. M. Eerikainen, “Detecting Atrial Fibrillation and Atrial Flutter in Daily Life Using Photoplethysmography Data,” IEEE J. Biomed. Heal. Informatics, vol. 24, no. 6, pp. 1610–1618, 2020, doi: 10.1109/JBHI.2019.2950574.
E. L. Johnson, “Thinner biological tissues induce leaflet flutter in aortic heart valve replacements,” Proc. Natl. Acad. Sci. U. S. A., vol. 117, no. 32, pp. 19007–19016, 2020, doi: 10.1073/pnas.2002821117.
J. F. Seymour, “Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial,” Blood, vol. 142, no. 8, pp. 687–699, 2023, doi: 10.1182/blood.2022018818.
H. Guo, “Meshless numerical approach to flutter analysis of rotating pre-twisted nanocomposite blades subjected to supersonic airflow,” Eng. Anal. Bound. Elem., vol. 132, pp. 1–11, 2021, doi: 10.1016/j.enganabound.2021.07.008.
M. Eugeni, “Numerical and experimental investigation of piezoelectric energy harvester based on flag-flutter,” Aerosp. Sci. Technol., vol. 97, 2020, doi: 10.1016/j.ast.2019.105634.
T. D. Bahnson, “Association between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial,” Circulation, vol. 145, no. 11, pp. 796–804, 2022, doi: 10.1161/CIRCULATIONAHA.121.055297.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Supriyono Supriyono, Rigen Ferdian Saputra, Ahmad Hilmy Zainuddin, M. Ivan Fairuz Akbar, M. Firdaus Habibillah, Ade Hasbulah
This work is licensed under a Creative Commons Attribution 4.0 International License.
